FOLFIRI+ƒUƒ‹ƒgƒ‰ƒbƒv
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 @
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ -- ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒUƒ‹ƒgƒ‰ƒbƒv 4 mg/‡s š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒŒƒ{ƒzƒŠƒi[ƒg 200 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒCƒŠƒmƒeƒJƒ“ 180 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
5-FU 400 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
5-FU 2400 mg/‡u  >> @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz
”²Ž•Œγ“™ˆ’u‚Μ‘n‚Μ‰ρ•œ‚ͺ’x‚κ‚ι‚±‚Ζ‚ͺ‚ ‚θ‚ά‚·